BioCore CRO and Biotechnology Division offers an integrated suite of bioanalytical and central lab services using
genome technology that include phase 1 metabolism and pharmacokinetics bioanalysis, bioequivalence study conduct, radiolabeled ADME services, phamacogenetic test for precision medicine, and clinical setup and monitoring expertise. BioCore is always growing its technology portfolio to specifically support innovation in drug development in both Korea and globally. We are your proven partner for success.